The IWF reports that as a consequence of the IOC’s reanalyses of samples from the 2012 London Olympic Games, the samples of the following Athletes have returned Adverse Analytical Findings:

AUKHADOV, Apti (RUS) – Dehydrochlormethyltestosterone, Drostanolone (S1.1 Anabolic agents)

KOSTOVA, Boyanka (AZE) – Dehydrochlormethyltestosterone, Stanozolol (S1.1 Anabolic agents)

PODOBEDOVA, Svetlana (KAZ) – Stanozolol (S1.1 Anabolic agents)

SAZANAVETS, Dzina (BLR) – Drostanolone, Stanozolol (S1.1 Anabolic agents)

SHKERMANKOVA, Maryna (BLR) – Dehydrochlormethyltestosterone, Stanozolol (S1.1 Anabolic agents)

KALINA, Yuliya (UKR) – Dehydrochlormethyltestosterone (S1.1 Anabolic agents)

ZHARNASEK, Yauheni (BLR) – Dehydrochlormethytestosterone, Stanozolol, Oxandrolone (S1.1 Anabolic agents)

MANEZA, Maiya (KAZ) – Stanozolol (S1.1 Anabolic agents)

ILYIN, Ilya (KAZ) – Dehydrochlormethyltestosterone, Stanozolol (S1.1 Anabolic agents)

CHINSHANLO, Zulfiya (KAZ) – Oxandrolone, Stanozolol (S1.1 Anabolic agents)

In line with the relevant rules and regulations, the IWF imposed mandatory provisional suspensions upon the Athletes, who remain provisionally suspended in view of potential anti-doping rule violations until their cases are closed.

Following the IOC’s decisions, the IWF will be in a position to take over the results management of these cases.

The IWF will report the current standing of the Beijing reanalytical cases as soon as possible.

Should it be determined in any of the cases that no anti-doping violation was committed, the relevant decision shall also be published.

The IWF will not make any further comments on the cases until they are closed.